ResMed Inc.
RMD
$255.83
$0.790.31%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.92% | 4.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.92% | 4.36% | |||
| Cost of Revenue | -2.24% | 0.13% | |||
| Gross Profit | -0.10% | 7.18% | |||
| SG&A Expenses | -2.24% | 8.08% | |||
| Depreciation & Amortization | -7.13% | 16.12% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.04% | 3.00% | |||
| Operating Income | 1.27% | 7.11% | |||
| Income Before Tax | -2.46% | 9.66% | |||
| Income Tax Expenses | 25.41% | 48.80% | |||
| Earnings from Continuing Operations | -8.21% | 4.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.21% | 4.02% | |||
| EBIT | 1.27% | 7.11% | |||
| EBITDA | -1.99% | 10.82% | |||
| EPS Basic | -8.02% | 4.19% | |||
| Normalized Basic EPS | 1.53% | 9.46% | |||
| EPS Diluted | -8.18% | 4.07% | |||
| Normalized Diluted EPS | 1.43% | 9.41% | |||
| Average Basic Shares Outstanding | -0.20% | -0.17% | |||
| Average Diluted Shares Outstanding | -0.09% | -0.12% | |||
| Dividend Per Share | 13.21% | 0.00% | |||
| Payout Ratio | 0.23% | -0.04% | |||